Page 5 - Harvard Bioscience News Today

StockNews.com assumed coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the medical instruments supplier’s stock. Several other research analysts have also recently weighed in on the company. Benchmark boosted their price objective on Harvard Bioscience from $4.00 to […]

/PRNewswire/ -- The "Global Internet Of Things in Logistics Market by Software, Hardware, Organization Size, Application - Cumulative Impact of COVID-19,...

Acumen Research and Consulting recently published report titled “Electrophoresis Reagents Market 2023 - 2032”...

Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass.,...

HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual

HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim...

Harvard Bioscience (NASDAQ:HBIO – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, August 8th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Harvard Bioscience Price Performance […]

HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended...

HOLLISTON, Mass., July 27, 2023 -- Harvard Bioscience, Inc. will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a...